Palantir Technologies Inc (NYSE:PLTR) shares jumped 20% to astir $152 successful aboriginal commercialized connected Tuesday the institution reported 2nd 4th 2026 results that exceeded Wall Street expectations for some net and revenue.
The institution reported adjusted net per stock of $0.41, compared with the $0.35 statement estimate, portion gross roseate 93% twelvemonth implicit twelvemonth to $1.935 billion, supra expectations of $1.80 billion.
US gross accrued 115% to $1.573 billion, including a 149% summation successful US commercialized gross to $764 million. US authorities gross roseate 90% to $809 million.
Palantir closed 220 deals worthy astatine slightest $1 cardinal during the quarter, including 73 deals of astatine slightest $10 million. Total declaration worth accrued 49% twelvemonth implicit twelvemonth to $3.373 billion, portion U.S. commercialized TCV roseate 153% to $2.132 billion.
GAAP operating income reached $912 million, representing a 47% margin, portion adjusted operating income was $1.194 billion, oregon a 62% margin. GAAP nett income was $1.062 billion, with adjusted escaped currency travel of $1.220 billion.
"This 4th was otherworldly," Palantir CEO Alex Karp said successful a statement. "Demand for AI sovereignty has present been unleashed. And Palantir is the lone institution that has demonstrated it tin alteration tokens into existent economical value."
For the 3rd quarter, Palantir expects gross of $2.160 cardinal to $2.164 cardinal and adjusted operating income of $1.292 cardinal to $1.296 billion.
The institution besides raised its afloat twelvemonth 2026 gross guidance to $8.150 cardinal to $8.158 billion, portion expanding its adjusted operating income outlook to $4.889 cardinal to $4.897 cardinal and adjusted escaped currency travel guidance to $4.5 cardinal to $4.7 billion. It besides expects US commercialized gross to transcend $3.424 billion, representing maturation of astatine slightest 134%.
UBS analysts wrote that Palantir posted an "outstanding" acceleration successful growth, with full gross maturation reaching 93% and US commercialized maturation accelerating to 149%, supra their 135% to 140% expectation. They noted that each cardinal metric successful the 4th exceeded their exemplary and that the institution raised its full-year 2026 guidance crossed its large metrics.
The analysts wrote that determination was "zero grounds of accrued competition" affecting Palantir's results, addressing what they described arsenic a cardinal bear-case concern. They besides highlighted management's extremity of maintaining much than 100% maturation successful full US gross implicit the adjacent 18 months, penning that the commentary could propulsion retired the timeline for highest growth.
UBS raised its estimates substantially and wrote that the results could amended the mixed communicative astir the stock, citing the spread successful sentiment betwixt Palantir and peers, the company's guidance revisions and the imaginable benefits of its "sovereign AI" strategy.
The analysts maintained a 'Buy' standing and raised their terms people to $220 from $200. They wrote that astatine astir 44 times their revised 2027 escaped currency travel estimate, they viewed the shares arsenic undervalued comparative to Palantir's medium-term maturation and profitability.

3 weeks ago
19








English (CA) ·
English (US) ·
Spanish (MX) ·